Authors:
Agaoglu, L
Devecioglu, O
Anak, S
Karakas, Z
Yalman, N
Biner, B
Eryilmaz, E
Goksan, B
Unuvar, A
Agirbasli, H
Can, M
Bilgen, H
Gedikoglu, G
Citation: L. Agaoglu et al., Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey, J CHEMOTHER, 13(3), 2001, pp. 281-287
Authors:
Ericson, KG
Fadeel, B
Nilsson-Ardnor, S
Soderhall, C
Samuelsson, A
Janka, G
Schneider, M
Gurgey, A
Yalman, N
Revesz, T
Egeler, RM
Jahnukainen, K
Storm-Mathiesen, I
Haraldsson, A
Poole, J
de Saint Basile, G
Nordenskjold, M
Henter, JI
Citation: Kg. Ericson et al., Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis, AM J HU GEN, 68(3), 2001, pp. 590-597
Authors:
Agirbasli, H
Anak, S
Yalman, N
Bilgen, H
Ozgenc, S
Can, E
Gedikoglu, G
Citation: H. Agirbasli et al., Abstracts of the 4th International Symposium on Febrile Neutropenia - December 15-17, 1999, SUPP CARE C, 8(2), 2000, pp. 145-161
Authors:
Sarper, N
Ozbek, U
Agaoglu, L
Ozgen, U
Eryilmaz, E
Yalman, N
Anak, S
Devecioglu, O
Gedikoglu, G
Citation: N. Sarper et al., Is AML1/ETO gene expression a good prognostic factor in pediatric acute myeloblastic leukemia?, PED HEM ONC, 17(7), 2000, pp. 577-583
Citation: N. Sarper et N. Yalman, FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children, MED PED ONC, 34(2), 2000, pp. 163-163